Pamela Ann Connealy - Net Worth and Insider Trading
Pamela Ann Connealy Net Worth
The estimated net worth of Pamela Ann Connealy is at least $4 Million dollars as of 2024-11-29. Pamela Ann Connealy is the CFO & COO of Pyxis Oncology Inc and owns about 2,314,886 shares of Pyxis Oncology Inc (PYXS) stock worth over $4 Million. Details can be seen in Pamela Ann Connealy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pamela Ann Connealy has not made any transactions after 2024-11-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pamela Ann Connealy
Pamela Ann Connealy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pamela Ann Connealy owns 5 companies in total, including Immunovant Inc (IMVTU) , Immunovant Inc (IMVT) , and Pyxis Oncology Inc (PYXS) among others .
Click here to see the complete history of Pamela Ann Connealy’s form 4 insider trades.
Insider Ownership Summary of Pamela Ann Connealy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IMVTU | Immunovant Inc | 2020-05-15 | Chief Financial Officer |
| IMVT | Immunovant Inc | 2019-12-18 | Chief Financial Officer |
| PYXS | Pyxis Oncology Inc | 2023-09-28 | Chief Financial Officer |
 | | 2023-01-26 | director |
| | 2023-07-20 | director |
Pamela Ann Connealy Latest Holdings Summary
Pamela Ann Connealy currently owns a total of 1 stock. Pamela Ann Connealy owns 2,314,886 shares of Pyxis Oncology Inc (PYXS) as of November 26, 2024, with a value of $4 Million.
Latest Holdings of Pamela Ann Connealy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PYXS | Pyxis Oncology Inc | 2024-11-26 | 2,314,886 | 1.83 | 4,236,241 |
Holding Weightings of Pamela Ann Connealy
Pamela Ann Connealy Form 4 Trading Tracker
According to the SEC Form 4 filings, Pamela Ann Connealy has made a total of 5 transactions in Pyxis Oncology Inc (PYXS) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Pyxis Oncology Inc is the acquisition of 88,850 shares on November 26, 2024, which cost Pamela Ann Connealy around $174,146.
Insider Trading History of Pamela Ann Connealy
- 1
Pamela Ann Connealy Trading Performance
GuruFocus tracks the stock performance after each of Pamela Ann Connealy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pamela Ann Connealy is -4.43%. GuruFocus also compares Pamela Ann Connealy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pamela Ann Connealy within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pamela Ann Connealy's insider trading performs compared to the benchmark.
Performance of Pamela Ann Connealy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.75 | | | | | |
| Relative Return to S&P 500(%) | -8.35 | | | | | |
Pamela Ann Connealy Ownership Network
Pamela Ann Connealy Owned Company Details
What does Immunovant Inc do?
Who are the key executives at Immunovant Inc?
Pamela Ann Connealy is the Chief Financial Officer of Immunovant Inc. Other key executives at Immunovant Inc include 10 percent owner Roivant Sciences Ltd. , Chief Dev. & Tech. Officer Julia G. Butchko , and Chief Scientific Officer Michael James Elliott .
Immunovant Inc (IMVTU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Immunovant Inc (IMVTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunovant Inc (IMVTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Immunovant Inc (IMVTU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunovant Inc Insider Transactions
Pamela Ann Connealy Mailing Address
Above is the net worth, insider trading, and ownership report for Pamela Ann Connealy. You might contact Pamela Ann Connealy via mailing address: 320 W 37th Street, 3rd Floor, New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
